Brian Dorsey
CIK 1380762 · Chief Operating Officer · last filed 2026-01-05
Brian Dorsey is a Chief Operating Officer who has filed 52 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for SPRY, was dated Jan 5, 2026. Across all open-market trades the lifetime net is −$2.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $105.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$105.3K
4
52
-$2.70M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPRY | Chief Operating Officer | 10,789 | $9.76 | $105.3K | -$1.82M | 8 | 2026-01-05 |
| SEELOS THERAPEUTICS, INC. (APRI) Delisted | SVP, Chief Development Officer | 159,116 | — | — | $10.5K | 13 | 2018-09-04 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | SVP Research | 62,426 | — | — | $0 | 2 | 2014-10-10 |
| Pernix Sleep, Inc. (SOMX) Delisted | SVP, Technical Operations | 52,264 | — | — | -$887.0K | 28 | 2013-01-03 |
Recent Filings
52 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-05 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2025-11-14 | SPRY | Mixed | — | -$176.1K | EDGAR |
| 2025-01-03 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2024-12-13 | SPRY | Mixed | — | -$468.3K | EDGAR |
| 2024-08-21 | SPRY | Mixed | — | -$718.0K | EDGAR |
| 2024-08-15 | SPRY | Mixed | — | -$370.8K | EDGAR |
| 2024-01-04 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2023-01-05 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2018-09-04 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Mixed | +38,550 | -$14.3K | EDGAR |
| 2018-01-03 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Mixed | −5,485 | -$10.1K | EDGAR |